Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Humira Pen

Adalimumab

Open in the dashboard

Part D claims

59,338

Prescriptions dispensed, refills included

Drug cost

$469,745,865

Paid at the pharmacy, in all

Prescribers

2,955

With 11 or more claims of it

In 2024, Medicare Part D recorded 59,338 claims for Humira Pen (adalimumab) from 2,955 prescribers, at a total drug cost of $469.7 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 51 states and territories
Part D claims for Humira Pen by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 288 6,600 $49,733,851
PA 167 4,072 $32,713,752
MI 150 3,491 $28,329,242
TX 167 3,302 $26,057,240
NY 184 3,180 $25,796,499
MA 123 2,703 $21,808,435
FL 159 2,598 $19,882,788
IL 96 1,986 $16,256,592
NC 101 1,983 $15,636,391
OH 110 1,799 $14,447,201
GA 75 1,701 $13,199,324
KY 69 1,580 $12,128,002
TN 75 1,557 $12,427,053
NJ 87 1,534 $12,069,165
SC 63 1,381 $11,884,682
The other 36 states and territories
State Prescribers Claims Drug cost
MS 21 1,244 $8,514,751
MN 61 1,195 $9,765,868
MO 61 1,171 $10,199,515
CO 61 1,136 $8,702,042
WA 64 1,134 $8,939,364
WI 60 1,071 $8,263,815
LA 46 1,010 $7,916,561
IN 51 935 $7,689,944
MD 53 841 $7,103,412
VA 50 808 $6,384,662
AL 45 807 $6,322,775
OK 40 703 $5,579,192
AZ 43 701 $6,200,948
OR 33 583 $4,409,354
IA 28 565 $4,519,971
PR 22 541 $4,002,499
NM 21 500 $3,923,891
WV 25 492 $4,042,067
ME 20 485 $3,978,217
AR 27 470 $3,623,806
NH 22 402 $3,208,310
CT 24 390 $3,296,142
KS 19 383 $2,947,681
NV 16 277 $2,179,885
NE 15 258 $1,991,225
UT 18 251 $1,996,306
MT 14 232 $1,595,348
SD 15 218 $1,485,186
DC 9 175 $1,352,046
ID 11 166 $1,448,744
RI 11 159 $1,206,721
ND 9 143 $1,108,750
DE 8 142 $1,109,298
AK 8 109 $1,002,931
WY 5 89 $769,630
VT 5 85 $594,795

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 32
Part D claims for Humira Pen by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 1,108 28,465 $223,513,468
Gastroenterology 446 6,693 $56,826,939
Nurse Practitioner 307 5,676 $43,218,763
Internal Medicine 300 5,630 $43,636,030
Dermatology 330 5,196 $41,924,820
Physician Assistant 232 3,887 $30,816,174
Family Practice 135 1,863 $14,705,171
Allergy/ Immunology 8 284 $1,979,083
Student in an Organized Health Care Education/Training Program 20 276 $2,042,787
General Practice 12 250 $1,723,538
Pulmonary Disease 10 230 $2,428,849
Pediatric Medicine 2 149 $1,280,595
Pharmacist 4 126 $975,098
Hospitalist 6 100 $715,109
Ophthalmology 5 91 $767,979

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Charles King Rheumatology MS 744 $5,069,969 None on record
Ramachandran Srinivasan Rheumatology CA 253 $1,642,565 None on record
David Pugliese Rheumatology PA 221 $1,761,259 None on record
Srikanth Naramala Rheumatology CA 205 $1,428,324 None on record
Christy Park Rheumatology TN 203 $1,449,014 $6

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for adalimumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record